Cancer Research UK, by way of its commercial division known as Cancer Research Technology, will collaborate with Abcodia on new blood tests designed to spot cancers at very early stages. Their work will focus, in part, on identifying biomarkers that will let clinicians detect cancer before patients even have symptoms. And they'll try to fill a diagnostic gap, focusing on cancers for which many screening tests aren't widely in use. Item